Skip to main content

Site notifications

Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Beximco Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (8)
Prescription medicine registration (3)

Date

2022 (1)
2021 (1)
2020 (5)
2019 (3)
2017 (1)

Search

Sponsor content

11 result(s) found, displaying 1 to 10

Beximco Pharmaceuticals Australia Pty Ltd - Lubricant, eye Cancelled under Section 41GL(d) of the Act

1 June 2022

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
PHARMACY CHOICE CHLORAMPHENICOL EYE DROPS chloramphenicol 5 mg/mL eye drop solution bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
BPA SITAGLIPTIN TABLET (Beximco Pharmaceuticals Australia Pty Ltd)

10 November 2020

Prescription medicine registration

Active ingredients: sitagliptin phosphate.
PHARMACY HEALTH CHLORAMPHENICOL EYE DROPS 5 mg/mL solution bottle Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
PRICELINE PHARMACY CHLORAMPHENICOL EYE DROPS 5 mg/mL solution bottle Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
TERRYWHITE CHEMMART CHLORAMPHENICOL EYE DROPS 5 mg/mL solution bottle Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
BPA-FLECAINIDE (Beximco Pharmaceuticals Australia Pty Ltd)

20 March 2020

Prescription medicine registration

Active ingredients: flecainide acetate.
BACTISIG chloramphenicol 5mg/mL (0.5%) eye drops solution bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
AMCAL CHLORAMPHENICOL 5 mg/mL (0.5%) eye drops solution bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd
Momvit Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Beximco Pharmaceuticals Australia Pty Ltd

Pages

Current page 1
Page 2
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia